
Opinion|Videos|July 23, 2024
NCCN Recommendations by PD-L1 Expression Level
A panel of experts discuss how the NCCN guideline recommendations differ for patients with and without PD-L1 expression.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do the NCCN guideline recommendations differ for patients without PD-L1 expression (<1%) compared with those with low (1%-49%) or high (≥50%) expression?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
2
Explore the Clinical Data for JOURNAVX® (suzetrigine)
3
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
4
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
5














































